Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials

BACKGROUND AND AIMS: Pioglitazone targets multiple pathogenic pathways involved in the development of cardiovascular diseases (CVD). The aim of this systematic review and meta-analysis is to assess the effects of pioglitazone treatment on the secondary prevention of CVD. METHODS: Randomized-controll...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Marit, van der Worp, H. Bart, van der Graaf, Yolanda, Visseren, Frank L. J., Westerink, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644073/
https://www.ncbi.nlm.nih.gov/pubmed/29037211
http://dx.doi.org/10.1186/s12933-017-0617-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644073/
https://www.ncbi.nlm.nih.gov/pubmed/29037211
http://dx.doi.org/10.1186/s12933-017-0617-4

Ejemplares similares